Literature DB >> 24839495

Pure malignant rhabdoid tumour of the bladder.

Katherine Sarah Warren1, Jon Oxley2, Anthony Koupparis1.   

Abstract

We present the case of a 17-year-old girl with pure malignant rhabdoid tumour of the bladder treated with a multimodal approach. She is recurrence-free at her 1-year follow-up.

Entities:  

Year:  2014        PMID： 24839495      PMCID： PMC4001656          DOI： 10.5489/cuaj.1633

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  10 in total

Review 1.  Pure rhabdoid tumor of the bladder.

Authors:  M Duvdevani; D Nass; Y Neumann; I Leibovitch; J Ramon; Y Mor
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

2.  Malignant extrarenal rhabdoid tumor of the bladder: 9-year survival after chemotherapy and partial cystectomy.

Authors:  Joseph H Chang; Armen H Dikranian; William H Johnston; Susan K Storch; Richard S Hurwitz
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

Review 3.  Synchronous perivesical and renal malignant rhabdoid tumor in a 9-year-old boy: a case report and review of literature.

Authors:  Konrad M Szymanski; Christian H Tabib; Muhammad T Idrees; Mark P Cain
Journal:  Urology       Date:  2013-07-03       Impact factor: 2.649

4.  Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.

Authors:  Tanya M Tekautz; Christine E Fuller; Susan Blaney; Maryam Fouladi; Alberto Broniscer; Thomas E Merchant; Matthew Krasin; James Dalton; Gregory Hale; Larry E Kun; Dana Wallace; Richard J Gilbertson; Amar Gajjar
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

Review 5.  Molecularly confirmed primary malignant rhabdoid tumor of the urinary bladder: implications of accurate diagnosis.

Authors:  Natasha Savage; Dan Linn; Colleen McDonough; Jeffrey M Donohoe; Arie Franco; Victor Reuter; Paul W Biddinger; Katherine W Eaton; Jaclyn A Biegel; Suash Sharma
Journal:  Ann Diagn Pathol       Date:  2011-07-19       Impact factor: 2.090

6.  Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor.

Authors:  Gail E Tomlinson; Norman E Breslow; Jeffrey Dome; Katherine Adams Guthrie; Pat Norkool; Sierra Li; Patrick R M Thomas; Elizabeth Perlman; J Bruce Beckwith; Giulio J D'Angio; Daniel M Green
Journal:  J Clin Oncol       Date:  2005-10-20       Impact factor: 44.544

7.  Renal and extrarenal rhabdoid tumors in children: a clinicopathologic study of 14 patients.

Authors:  C Sotelo-Avila; F Gonzalez-Crussi; D deMello; C Vogler; W M Gooch; G Gale; R Pena
Journal:  Semin Diagn Pathol       Date:  1986-05       Impact factor: 3.464

8.  Extra-renal non-cerebral rhabdoid tumours.

Authors:  Franck Bourdeaut; Paul Fréneaux; Bénédicte Thuille; Christophe Bergeron; Valérie Laurence; Laurence Brugières; Cécile Vérité; Jean Michon; Olivier Delattre; Daniel Orbach
Journal:  Pediatr Blood Cancer       Date:  2008-09       Impact factor: 3.167

Review 9.  Extracranial rhabdoid tumours: what we have learned so far and future directions.

Authors:  Bernadette Brennan; Charles Stiller; Franck Bourdeaut
Journal:  Lancet Oncol       Date:  2013-07       Impact factor: 41.316

10.  Surgery and actinomycin improve survival in malignant rhabdoid tumor.

Authors:  Ryan Horazdovsky; J Carlos Manivel; Edward Y Cheng
Journal:  Sarcoma       Date:  2013-02-03
  10 in total
  3 in total

1.  Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets.

Authors:  A Porrello; R B Piergentili
Journal:  Curr Genomics       Date:  2016-02       Impact factor: 2.236

2.  Genetics of Bladder Malignant Tumors in Childhood.

Authors:  Andrea Zangari; Johan Zaini; Caterina Gulìa
Journal:  Curr Genomics       Date:  2016-02       Impact factor: 2.236

Review 3.  Unusual Faces of Bladder Cancer.

Authors:  Claudia Manini; José I López
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.